AAP
TWST icon

Arax Advisory Partners’s Twist Bioscience TWST Stock Holding History

Arax Advisory Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
1,057
+968
+1,088% +$63K ﹤0.01% 2671
2026
Q1 		$4.23K Buy
89
+17
+24% +$762 ﹤0.01% 2867
2025
Q4 		$2.28K Sell
72
-535
-88% -$16.7K ﹤0.01% 3211
2025
Q3 		$17.1K Buy
+607
New +$18.4K ﹤0.01% 2340
2024
Q3 		– Sell
-64
Closed -$3.15K – 2656
2024
Q2 		$3.15K Buy
+64
New +$2.61K ﹤0.01% 1807

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Arax Advisory Partners's TWST Position: Q2 2026 in Review

Arax Advisory Partners increased its Twist Bioscience (TWST) stake by 1,088% in Q2 2026, buying an estimated $63K and bringing the position to 1,057 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Arax Advisory Partners first reported a position in TWST in Q2 2024 and has held it in 5 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Arax Advisory Partners held 1,057 shares of Twist Bioscience worth $109K as of Q2 2026.
  • Arax Advisory Partners bought 968 Twist Bioscience shares in Q2 2026, an estimated $63K.
  • Twist Bioscience made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2671 holding.
  • Arax Advisory Partners first reported a position in Twist Bioscience in Q2 2024 and has held it in 5 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.